Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Danaher 1Q Profit Rises 43% On Strong Revenue Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 12:54pm CET

Danaher Corp.'s (>> Danaher Corporation) first-quarter earnings rose 43% as the diversified manufacturer's revenue growth got a boost from acquisitions.

For the current quarter, Danaher forecast per-share earnings of 76 cents to 81 cents, including anticipated dilution of a penny from its recent deal to acquire X-Rite Inc. (XRIT). Analysts polled by Thomson Reuters expected per-share earnings of 82 cents.

The company narrowed its 2012 per-share earnings estimate to $3.25 to $3.35 from its previous range of $3.20 to $3.35. The new forecast includes 3 cents of anticipated dilution related to X-Rite.

Danaher has remained acquisitive, mostly focusing its efforts on medical technology, testing and measurement and dental equipment. The acquisition of Beckman Coulter last year for $5.78 billion was Danaher's largest deal and gives the company a stronger foothold in the growing diagnostics industry.

More recently Danaher reached a $478 million deal for color-measurement technology company X-Rite in a move Danaher expects will complement its Esko digital design capabilities and further its lead in the product identification industry.

President and Chief Executive H. Lawrence Culp Jr. said the company was encouraged by the quarter-to-quarter business improvement and expects that core growth will accelerate in the second quarter.

Danaher reported a profit of $612.9 million, or 86 cents a share, up from $429.4 million, or 63 cents a share, a year earlier. Earnings from continuing operations were up at 73 cents from 61 cents. Danaher in January had projected earnings of 66 cents to 71 cents.

Revenue increased 31% to $4.32 billion. Excluding acquisitions and currency fluctuations, revenue was up 1.5%

Analysts recently projected $4.33 billion.

Gross margin fell to 51.8% from 53.1%.

Shares closed Wednesday at $54.69 and were inactive premarket.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Danaher Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER CORPORATION
01/11 DANAHER : Schedules Fourth Quarter 2016 Earnings Conference Call
01/11 DANAHER CORPORATION (NASDAQ : DHR) Files An 8-K Results of Operations and Financ..
01/10 DANAHER CORPORATION (NYSE : DHR) Files An 8-K Results of Operations and Financia..
01/10 DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
01/04 DANAHER : To Present At J.P. Morgan Healthcare Conference
2016 DANAHER CORPORATION : ex-dividend day
2016 DANAHER : Initiates 2017 Outlook
2016 DANAHER CORPORATION : Declares Dividend of $0.1250.
2016 DANAHER CORP /DE/ : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Y..
2016 DANAHER : Announces Quarterly Dividend
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
2016 EXCLUSIVE : U.S. regulator poised to approve Abbott purchase of St Jude - source..
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/13 Pentair, Roper upgraded at J.P. Morgan on Trump effect; GE a "top avoid"
01/11 Medtech Mergers And Acquisitions Regresses To The Mean In 2016
01/11 Danaher Corporation (DHR) presents at 35th Annual J.P. Morgan Healthcare Conf..
01/04 Political Ructions, Poor Deal-Making And Scandal - A Bad Year For Big-Cap Med..
2016 ESCO Technologies - A Tough Mix Of Potential And Past Performance
Advertisement
Financials ($)
Sales 2016 16 842 M
EBIT 2016 2 945 M
Net income 2016 2 320 M
Debt 2016 10 318 M
Yield 2016 0,70%
P/E ratio 2016 25,58
P/E ratio 2017 25,27
EV / Sales 2016 3,95x
EV / Sales 2017 3,52x
Capitalization 56 277 M
More Financials
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 89,8 $
Spread / Average Target 10%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER CORPORATION4.52%56 277
THERMO FISHER SCIENTIF..3.68%57 788
BOSTON SCIENTIFIC CORP..10.12%32 435
PHILIPS-1.83%28 197
INTUITIVE SURGICAL, IN..4.82%25 756
ILLUMINA, INC.26.97%23 882
More Results